Primary Care and the Opioid-Overdose Crisis - Buprenorphine Myths and Realities

N Engl J Med. 2018 Jul 5;379(1):1-4. doi: 10.1056/NEJMp1802741.

Authors

Sarah E Wakeman¹, Michael L Barnett¹

Affiliation

¹ From the Department of Medicine, Massachusetts General Hospital (S.E.W.); the Department of Medicine, Harvard Medical School (S.E.W., M.L.B.), the Department of Health Policy and Management, Harvard T.H. Chan School of Public Health (M.L.B.); and the Division of General Internal Medicine and Primary Care, Department of Medicine, Brigham and Women's Hospital (M.L.B.) - all in Boston.

PMID: 29972748
DOI: 10.1056/NEJMp1802741

No abstract available

MeSH terms

Buprenorphine / therapeutic use*
Drug Overdose / mortality
Drug Utilization / trends
Education, Medical
Government Regulation*
Humans
Narcotic Antagonists / therapeutic use*
Opioid-Related Disorders / drug therapy*
Opioid-Related Disorders / epidemiology
Physicians, Primary Care
Primary Health Care*
United States / epidemiology

Substances

Narcotic Antagonists
Buprenorphine